Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience-Reference-Cited by-同舟云学术

Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience

Published:2017-02-20 Issue:6 Volume:105 Page:769-776
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Molteni Alfredo^ORCID,Riva Marta,Ravano Emanuele,Marbello Laura,Mancini Valentina,Grillo Giovanni,Zucchetti Elisa,Greco Rosa,Cairoli Roberto

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-017-2198-0.pdf

Reference28 articles.

1. Schiffer CA. Acute myeloid leukemia in adults: where do we go from here? Cancer Chemother Pharmacol. 2001;48(suppl):S45–52.

2. Mandelli F, Vignetti M, Suciu S, Stasi R, Petti MC, Meloni G, et al. Daunorubicin versus mitoxantrone versus idarubicin as induction an consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10. J Clin Oncol. 2009;27:5397–403.

3. Willemze R, Suciu S, Meloni G, Labar B, Marie JP, Halkes CJ, et al. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMAAML-12 Trial. J Clin Oncol. 2014;32(3):219–28.

4. Löwenberg B, Pabst T, Vellenga E, van Putten W, Schouten HC, Graux C, et al. Cytarabine dose for acute myeloid leukemia. N Engl J Med. 2011;364(11):1027–36.

5. Gardin C, Turlure P, Fagot X, Thomas X, Terre C, Contentin T, et al. Postremission treatment of elderly patients with AML in first CR after IC: results of the multicenter randomized ALFA 9803 trial. Blood. 2007;109:5129–35.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia;International Journal of Molecular Sciences;2024-01-12

2. Clinical Outcomes in Patients with FLT3-ITD-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Quizartinib or Salvage Chemotherapy in the QuANTUM-R Trial;Transplantation and Cellular Therapy;2021-02

3. Successful combination chemotherapy involving clofarabine, cyclophosphamide, and etoposide for pediatric relapsed acute myeloid leukemia: A case report;SAGE Open Medical Case Reports;2021-01

4. Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC;Annals of Hematology;2020-06-20

5. A real-world study on Clofarabine and Cytarabine combination in patients with relapsed/refractory acute myeloid leukemia;Mediterranean Journal of Hematology and Infectious Diseases;2019-04-29